Tissue Engineered - Skin Substitutes Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Tissue Engineered - Skin Substitutes Market
Tissue Engineered - Skin Substitutes Market: By Duration (Permanent, Semi-Permanent);By Anatomical Structure (Dermal, Epidermal, Dermal-Epidermal); By Biomaterial (Autologous, Allogeneic, Xenogeneic); By product (Synthetic Skin substitute, Biosynthetic, Biological, Amnion and others); By Technology (Laser assisted bio-printing, 3D, Robotic technology and others)By Application (Chronic wounds, Burns cases, Traumatic Wounds, Diabetic/Vascular Ulcer and others); By End users (Hospitals and other Healthcare facilities)& Geographic Analysis - Forecast (2018-2023)
Report Code : HCR 0408
Updated Date: 11 December, 2018  
16

Copies sold

    Client Rating

1. Tissue Engineered Skin Substitutes  Market - Overview
1.1. Definitions and Scope
2. Tissue Engineered Skin Substitutes  Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Tissue Engineered Skin Substitutes  Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Tissue Engineered Skin Substitutes  Market Forces
4.1. Drivers
4.2. Constraints
4.3. Challenges
4.4. Porters five force model
4.4.1. Bargaining power of suppliers
4.4.2. Bargaining powers of customers
4.4.3. Threat of new entrants
4.4.4. Rivalry among existing players
4.4.5. Threat of substitutes 
5. Tissue Engineered Skin Substitutes  Market -Strategic analysis
5.1. Value chain analysis
5.2. Opportunities analysis
5.3. Product life cycle
6. Tissue Engineered Skin Substitutes  Market– By Duration (Market Size -$Million / $Billion)
6.1. Segment type Size and Market Share Analysis 
6.2. Application  Revenue and Trends
6.3. Segment Analysis by Type
6.3.1. Permanent
6.3.2. Semi-Permanent
7. Tissue Engineered Skin Substitutes  Market– By Anatomical Structure (Market Size -$Million / $Billion)
7.1. Segment type Size and Market Share Analysis 
7.2. Application Revenue and Trends 
7.3. Segment Analysis by Type
7.3.1. Dermal
7.3.2. Epidermal
7.3.3. Epidermal-dermal (Composite)
8. Tissue Engineered Skin Substitutes  Market– By Biomaterial (Market Size -$Million / $Billion)
8.1. Autologous
8.2. Allogeneic
8.2.1. Cellular allogeneic
8.2.2. Acellular allogeneic
8.3. Xenogeneic
8.4. Amnion
9. Tissue Engineered Skin Substitutes  Market– By Product (Market Size -$Million / $Billion)
9.1. Synthetic Skin substitutes
9.1.1. Biodegradable
9.1.2. Non-Biodegradable
9.2. Biosynthetic
9.3. Biological
9.4. Amnion
9.5. Others
10. Tissue Engineered Skin Substitutes  Market– By Technology (Market Size -$Million / $Billion)
10.1. Laser assisted bio-printing 
10.2. 3D
10.3. Robotic Technology
10.4. Others
11. Tissue Engineered Skin Substitutes  Market– By Application (Market Size -$Million / $Billion)
11.1. Chronic wounds
11.2. Burns cases
11.2.1. Heat
11.2.2. Electricity
11.2.3. Radiation
11.3. Traumatic Wounds
11.4. Diabetic/Vascular Ulcer
11.5. Others
12. Tissue Engineered Skin Substitutes  Market– By End User (Market Size -$Million / $Billion)
12.1. Segment type Size and Market Share Analysis 
12.2. Application Revenue and Trends
12.3. Application Segment Analysis by Type
12.3.1. Hospitals
12.3.1.1. Super specialty Hospitals
12.3.1.2. Multi-specialty Hospitals 
12.3.2. Other Healthcare Facilities
13. Tissue Engineered Skin Substitutes  Market- By Geography (Market Size -$Million / $Billion)
13.1. Tissue Engineered Skin Substitutes  Market - North America Segment Research
13.2. North America Market Research (Million / $Billion)
13.2.1. Segment type Size and Market Size Analysis 
13.2.2. Revenue and Trends
13.2.3. Application Revenue and Trends by type of Application
13.2.4. Company Revenue and Product Analysis
13.2.5. North America Product type and Application Market Size
13.2.5.1. U.S.
13.2.5.2. Canada 
13.2.5.3. Mexico 
13.2.5.4. Rest of North America
13.3. Tissue Engineered Skin Substitutes  Market- South America Segment Research
13.4. South America Market Research (Market Size -$Million / $Billion)
13.4.1. Segment type Size and Market Size Analysis 
13.4.2. Revenue and Trends
13.4.3. Application Revenue and Trends by type of Application
13.4.4. Company Revenue and Product Analysis
13.4.5. South America Product type and Application Market Size
13.4.5.1. Brazil  
13.4.5.2. Venezuela
13.4.5.3. Argentina
13.4.5.4. Ecuador
13.4.5.5. Peru
13.4.5.6. Colombia 
13.4.5.7. Costa Rica
13.4.5.8. Rest of South America
13.5. Tissue Engineered Skin Substitutes  Market- Europe Segment Research
13.6. Europe Market Research (Market Size -$Million / $Billion)
13.6.1. Segment type Size and Market Size Analysis 
13.6.2. Revenue and Trends
13.6.3. Application Revenue and Trends by type of Application
13.6.4. Company Revenue and Product Analysis
13.6.5. Europe Segment Product type and Application Market Size
13.6.5.1. U.K  
13.6.5.2. Germany 
13.6.5.3. Italy 
13.6.5.4. France
13.6.5.5. Netherlands
13.6.5.6. Belgium
13.6.5.7. Spain
13.6.5.8. Denmark
13.6.5.9. Rest of Europe
13.7. Tissue Engineered Skin Substitutes  Market– APAC Segment Research
13.8. APAC Market Research (Market Size -$Million / $Billion)
13.8.1. Segment type Size and Market Size Analysis 
13.8.2. Revenue and Trends
13.8.3. Application Revenue and Trends by type of Application
13.8.4. Company Revenue and Product Analysis
13.8.5. APAC Segment – Product type and Application Market Size
13.8.5.1. China 
13.8.5.2. Australia
13.8.5.3. Japan 
13.8.5.4. South Korea
13.8.5.5. India
13.8.5.6. Taiwan
13.8.5.7. Malaysia
13.8.5.8. Hong Kong  
13.8.5.9. Rest of APAC
13.9. Tissue Engineered Skin Substitutes  Market– Middle East Segment and Africa Segment Research
13.10. Middle East & Africa Market Research (Market Size -$Million / $Billion)
13.10.1. Segment type Size and Market Size Analysis 
13.10.2. Revenue and Trend Analysis
13.10.3. Application Revenue and Trends by type of Application 
13.10.4. Company Revenue and Product Analysis
13.10.5. Middle East Segment Product type and Application Market Size
13.10.5.1. Israel 
13.10.5.2. Saudi Arabia
13.10.5.3. UAE
13.10.6. Africa Segment Analysis
13.10.6.1. South Africa
13.10.6.2. Rest of Middle East & Africa
14. Tissue Engineered Skin Substitutes  Market - Entropy
14.1. New product launches
14.2. M&A's, collaborations, JVs and partnerships
15. Tissue Engineered Skin Substitutes  Market – Industry / Segment Competition landscape
15.1. Market Share Analysis
15.1.1. Market Share by Country- Top companies
15.1.2. Market Share by Region- Top 10 companies
15.1.3. Market Share by type of Application – Top 10 companies
15.1.4. Market Share by type of Product / Product category- Top 10 companies
15.1.5. Market Share at global level- Top 10 companies
15.1.6. Best Practices for companies
16. Tissue Engineered Skin Substitutes  Market – Key Company List by Country
17. Tissue Engineered Skin Substitutes  Market Company Analysis
17.1. Market Share, Company Revenue, Products, M&A, Developments
17.2. Celity L.P. Inc.
17.3. Smith & Nephew Plc
17.4. Integra Life Sciences Holdings Corporation
17.5. 3M Inc.
17.6. BSN Medical GmbH
17.7. Convatec Group Plc
17.8. Molnlycke Healthcare AB 
17.9. Company 8
17.10. Company 9
17.11. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"
18. Tissue Engineered Skin Substitutes  Market -Appendix
18.1. Abbreviations
18.2. Sources
19. Tissue Engineered Skin Substitutes  Market -Methodology
19.1. Research Methodology
19.1.1. Company Expert Interviews
19.1.2. Industry Databases
19.1.3. Associations
19.1.4. Company News
19.1.5. Company Annual Reports
19.1.6. Application Trends
19.1.7. New Products and Product database
19.1.8. Company Transcripts
19.1.9. R&D Trends
19.1.10. Key Opinion Leaders Interviews
19.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $7250
Related Reports
0px;">Scroll